GPAT3 and metabolic dysfunction-associated steatotic liver disease: Previous studies have shown that downregulation of GPAT3 and other triglyceride synthetic enzymes has a beneficial effect on HFD-induced hepatic lipid accumulation [45], underscoring the potential contribution of hepatic GPAT3 function to NAFLD.